The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

The Medicines competitive analysis

Loading summary...

Latest oppositions filed by The Medicines

Explore patent oppositions filed by The Medicines against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP1857547
Further Novel Forms Of Interfering Rna MoleculesATUGENOct 16, 2018
EP2258847
Futher Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICSDec 14, 2017

Latest patents of The Medicines opposed by its competitors

Explore The Medicines's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3529360
Apr 17, 2024Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein Reduction5

Latest PTAB cases involving The Medicines

Discover the latest PTAB cases involving The Medicines, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing The Medicines with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
THE MEDICINES UK2 - - -
ATUGEN - 3 - -
SILENCE THERAPEUTICS28 - 5